Home / Inspections / 1279132

FDA Inspection 1279132 — LifeSource-Upper Midwest OPO

LifeSource-Upper Midwest OPO — FEI 3000718539

The FDA completed an inspection of LifeSource-Upper Midwest OPO on July 30, 2025 in Minneapolis, MN. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 30, 2025
Fiscal Year
2025
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Minneapolis, MN (United States)

Facility

Other inspections at this facility

  • 1084827 (NAI Fri Mar 22 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1028803 (NAI Wed Sep 20 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 913084 (NAI Mon Feb 09 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 805924 (NAI Wed Oct 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 758993 (VAI Tue Jan 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources